Search Results - "Varkaris, A."

  • Showing 1 - 3 results of 3
Refine Results
  1. 1
    476P Allosteric PI3K-alpha inhibition reverses on-target resistance to orthosteric inhibitors mediated by secondary PIK3CA mutations

    476P Allosteric PI3K-alpha inhibition reverses on-target resistance to orthosteric inhibitors mediated by secondary PIK3CA mutations by Varkaris, A.

    Published in Annals of oncology (01-10-2023)
    Get full text
    Journal Article
    Save to List
    Saved in:
  2. 2
    190 (PB178): BH3 mimetics targeting BCL-XL have efficacy in solid tumors with RB1 loss and replication stress

    190 (PB178): BH3 mimetics targeting BCL-XL have efficacy in solid tumors with RB1 loss and replication stress by Varkaris, A., Wang, K., Kozlova, N., Nouri, M., Stavridi, A., Einstein, D., DeBono, J., Corey, E., Sharp, A., Balk, S.

    Published in European journal of cancer (1990) (01-10-2024)
    Get full text
    Journal Article
    Save to List
    Saved in:
  3. 3
    58 (PB046): Tumor-agnostic efficacy and safety of lirafugratinib, a highly selective FGFR2 inhibitor, in patients (pts) with advanced solid tumors with FGFR2 fusions or rearrangements (f/r): the ReFocus study

    58 (PB046): Tumor-agnostic efficacy and safety of lirafugratinib, a highly selective FGFR2 inhibitor, in patients (pts) with advanced solid tumors with FGFR2 fusions or rearrangements (f/r): the ReFocus study by Hollebecque, A., Dotan, E., Liao, C.Y.A., Roda, D., Fontana, E., Babiker, H., Kim, R.D., Oh, D.Y., Ghiringhelli, F., Moreno, I., Liu, J., Subbiah, V., Varkaris, A., Borad, M.J., Cassier, P.A., Deary, A., Ramirez, F.T., Ricard, F., Jen, K.Y., Schram, A.M.

    Published in European journal of cancer (1990) (01-10-2024)
    Get full text
    Journal Article
    Save to List
    Saved in:

Search Tools: